BlackRock’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
1,096,430
+23,158
+2% +$29.2K ﹤0.01% 4233
2025
Q4
$1.31M Sell
1,073,272
-347,591
-24% -$522K ﹤0.01% 4230
2025
Q3
$2.1M Sell
1,420,863
-709,656
-33% -$1.08M ﹤0.01% 4074
2025
Q2
$2.47M Sell
2,130,519
-3,111,240
-59% -$4.4M ﹤0.01% 4007
2025
Q1
$7.08M Buy
5,241,759
+61,782
+1% +$375K ﹤0.01% 3488
2024
Q4
$68.2M Sell
5,179,977
-38,988
-0.7% -$532K ﹤0.01% 2280
2024
Q3
$58.5M Buy
5,218,965
+247,326
+5% +$3.09M ﹤0.01% 2377
2024
Q2
$53.4M Buy
4,971,639
+316,254
+7% +$4.08M ﹤0.01% 2370
2024
Q1
$69.4M Sell
4,655,385
-146,132
-3% -$2.41M ﹤0.01% 2265
2023
Q4
$87M Buy
4,801,517
+478,916
+11% +$7.28M ﹤0.01% 2159
2023
Q3
$75M Sell
4,322,601
-84,219
-2% -$1.46M ﹤0.01% 2155
2023
Q2
$79.9M Buy
4,406,820
+2,578,692
+141% +$61M ﹤0.01% 2196
2023
Q1
$48.6M Buy
1,828,128
+332,626
+22% +$9.47M ﹤0.01% 2465
2022
Q4
$28.9M Buy
1,495,502
+126,382
+9% +$2.64M ﹤0.01% 2827
2022
Q3
$28.6M Buy
1,369,120
+483,034
+55% +$9.24M ﹤0.01% 2833
2022
Q2
$7.1M Sell
886,086
-812,126
-48% -$5.2M ﹤0.01% 3664
2022
Q1
$11.9M Buy
1,698,212
+10,338
+0.6% +$105K ﹤0.01% 3479
2021
Q4
$22.8M Buy
1,687,874
+135,882
+9% +$2.16M ﹤0.01% 3187
2021
Q3
$26.2M Sell
1,551,992
-5,730
-0.4% -$122K ﹤0.01% 3103
2021
Q2
$45.4M Sell
1,557,722
-117,100
-7% -$3.65M ﹤0.01% 2764
2021
Q1
$65.9M Buy
1,674,822
+819,249
+96% +$26.6M ﹤0.01% 2440
2020
Q4
$19.4M Buy
855,573
+371,294
+77% +$9.31M ﹤0.01% 3022
2020
Q3
$11M Buy
484,279
+398,792
+466% +$9.97M ﹤0.01% 3172
2020
Q2
$2.77M Buy
+85,487
New +$2.27M ﹤0.01% 3726

Other funds holding PLRX